Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

fezakinumab MeSH Supplementary Concept Data 2025


MeSH Supplementary
fezakinumab
Unique ID
C000629141
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629141
Entry Term(s)
ILV-094
Pharm Action
Dermatologic Agents
Registry Numbers
0S77U25XZ3
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
10
Note
IL-22 monoclonal antibody for the treatment of atopic dermatitis
Source
J Am Acad Dermatol. 2018 May;78(5):872-881.e6.
Date of Entry
2018/12/03
Revision Date
2019/10/31
fezakinumab Preferred
ILV-094 Narrower
page delivered in 0.005s